Dolby Laboratories (DLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 628,371 | 867,257 | 908,838 | 1,064,432 | 1,233,032 |
| Marketable Securities | 189,213 | 156,812 | 141,688 | 80,618 | 38,839 |
| Receivables | 243,593 | 236,229 | 227,263 | 241,449 | 232,609 |
| Inventories | 23,549 | 24,096 | 16,623 | 13,144 | 10,965 |
| Other current assets | 176,093 | 170,402 | 258,846 | 226,809 | 182,316 |
| TOTAL | $1,310,894 | $1,504,719 | $1,621,570 | $1,695,145 | $1,760,498 |
| Non-Current Assets | |||||
| PPE Net | 513,481 | 517,870 | 527,623 | 533,706 | 534,381 |
| Investments And Advances | 102,514 | 106,726 | 124,142 | 120,988 | 62,819 |
| Intangibles | 477,412 | 487,533 | 498,019 | 465,701 | 463,584 |
| Other Non-Current Assets | 285,247 | 303,088 | 291,636 | 289,381 | 284,405 |
| TOTAL | $1,378,654 | $1,415,217 | $1,441,420 | $1,409,776 | $1,345,189 |
| Total Assets | $2,689,548 | $2,919,936 | $3,062,990 | $3,104,921 | $3,105,687 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 14,171 | 16,821 | 11,373 | 19,104 | 17,779 |
| Accrued Expenses | 230,237 | 229,267 | 228,545 | 225,847 | 262,728 |
| Other current liabilities | 18,588 | 21,216 | 22,109 | 21,426 | 18,473 |
| TOTAL | $277,518 | $285,485 | $280,959 | $283,290 | $315,717 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 161,007 | 174,913 | 177,044 | 179,114 | 185,701 |
| TOTAL | $161,010 | $174,926 | $176,843 | $179,110 | $185,738 |
| Total Liabilities | $438,528 | $460,411 | $457,802 | $462,400 | $501,455 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 95,958 | 97,677 | 100,895 | 101,818 | 101,161 |
| Common Shares | 94 | 98 | 99 | 100 | 100 |
| Retained earnings | 2,297,730 | 2,484,689 | 2,615,354 | 2,649,175 | 2,607,909 |
| Other shareholders' equity | -46,804 | -25,262 | -10,265 | -6,754 | -3,777 |
| TOTAL | $2,251,020 | $2,459,525 | $2,605,188 | $2,642,521 | $2,604,232 |
| Total Liabilities And Equity | $2,689,548 | $2,919,936 | $3,062,990 | $3,104,921 | $3,105,687 |